AAIC 2025 Abstract·26 DecEvaluating AR1001 as Monotherapy from a Phase 2 Study in Mild to Moderate Alzheimer’s Disease PatientsTrial in peopleInterventionsPaper
AAIC 2025 Abstract·24 DecInterlaboratory comparison of amyloid‐beta [AB1‐42], [AB1‐40] and its ratio derived from CSF at two reference laboratories using the lumipulse platformStudy in peopleBiomarkersPaper